Replies to post #332 on BiondVax Pharmaceuticals Ltd (BVXV)

[midastouch017]

any specific points of interest to recap on?

I have not expected any news yesterday
knowing that to divulge info not via
an official PR is not being done, not
by Prof Arnon that is.

My expectations were high due to the
large audience it attracted as well
as analysts.

As you know, at the moment the company
is hardly noticed, and well under the
radar, unlike many other small bios
who create a lot of noise over nothing.

Prof Arnon is a well spoken knowledgeable
scientist, with Copaxone in her credit,
if she is optimistic, as was yesterday,
so am I, and with sufficient proof as
of the present I am holding strong and long.

The chart clearly shows that the 'conversation'
had an immediate positive impact on px.

So, a short reply to your question: No
specific points of interest.

:-)